HOME >> BIOLOGY >> NEWS
Interferons effective against smallpox

BALTIMORE March 11, 2003 Proteins produced by the immune system, known as interferons, may be an effective treatment for smallpox, say researchers today at the American Society for Microbiologys Biodefense Research Meeting.

Certain cytokines, particularly interferons, are well known for their antiviral effects in various virus infections, says Ge Liu of Advanced Biosystems, Inc. in Manassas, Virginia, a lead researcher in the study, in collaboration with scientists from the Southern Research Institute in Frederick, Maryland, and George Mason University.

The researchers tested the ability of a number of interferons and interleukins, administered intranasally, to protect mice from a lethal infection with vaccinia virus, a close relative to the smallpox virus that is often used in mice to test potential smallpox treatments. Mice treated with interferons alpha and gamma had survival rates over 95 percent, compared to control groups in which no mice survived.

Intranasal administration of interferon alpha and interferon gamma provides nearly full protection against respiratory vaccinia virus infection in mice, says Liu. Therefore, our results have implications in the utilization of interferon as a prophylactic tool in a scenario of aerosol orthopoxvirus infection.

The American Society for Microbiology (ASM) is the largest single life science society, composed of over 42,000 scientists, teachers, physicians, and health professionals. Its mission is to promote research and training in the microbiological sciences and to assist communication between scientists, policymakers, and the public to improve health, economic well being, and the environment.


'"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
11-Mar-2003


Page: 1

Related biology news :

1. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
2. Endurance exercise found to be equally effective as diuretics in improving cardiac health
3. Purdue yeast makes ethanol from agricultural waste more effectively
4. Scientists learn how adjuvant makes vaccines effective
5. Super-effective jumping gene created
6. Drug combo effective in advanced breast cancer
7. Data show investigational antibiotic safe, effective in preventing travelers diarrhea
8. Mexican farmers effectively cultivate phenotypic diversity in maize
9. Newer drugs more effective at curing strep throat than penicillin
10. Researchers show chronic sinusitis is immune disorder; antifungal medicine effective treatment
11. Ribozyme package effective against hepatitis B virus

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/1/2016)... -- Favorable Government Initiatives Coupled With Implementation ... to Boost Global Biometrics System Market Through 2021  ... " Global Biometrics Market By Type, By End ... - 2021", the global biometrics market is projected to ... growing security concerns across various end use sectors such ...
(Date:5/20/2016)... 20, 2016  VoiceIt is excited to announce ... By working together, VoiceIt and VoicePass ... and VoicePass take slightly different approaches to voice ... security and usability. ... new partnership. "This marketing and technology ...
(Date:5/12/2016)... 2016 WearablesResearch.com , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. ... test has received AOAC Research Institute approval 061601. , “This is another AOAC-RI ... stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate ...
Breaking Biology Technology:
Cached News: